ABBOTT LABORATORIES (ABT) › Operating IncomeABBOTT LABORATORIES (ABT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2007: $4.58B2008: $5.69B2009: $6.24B2010: $6.09B2011: $1.63B2012: $1.36B2013: $2.13B2014: $2.60B2015: $2.87B2016: $3.03B2017: $1.56B2018: $3.65B2019: $4.53B2020: $5.36B2021: $8.43B2022: $8.36B2023: $6.48B2024: $6.83B2025: $8.05B$8.05B2007Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$8.05B+18.0%2024$6.83B+5.4%2023$6.48B-22.5%2022$8.36B-0.7%2021$8.43B+57.3%2020$5.36B+18.2%2019$4.53B+24.2%2018$3.65B+133.4%2017$1.56B-48.3%2016$3.03B+5.5%2015$2.87B+10.3%2014$2.60B+21.8%2013$2.13B+56.8%2012$1.36B-16.5%2011$1.63B-73.2%2010$6.09B-2.4%2009$6.24B+9.5%2008$5.69B+24.4%2007$4.58B—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share